Community-associated methicillin-resistant staphylococcus aureus (CA-MRSA) as a cause of hospital-acquired pneumonia (HAP) Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007
Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA) Source: Eur Respir J 2007; 30: Suppl. 51, 407s Year: 2007
Community-acquired pneumonia due to S. aureus Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011
MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia Source: Eur Respir J 2009; 34: 1470-1476 Year: 2009
Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006
MRSA as a cause of community-acquired pneumonia Source: Eur Respir J 2009; 34: 1013-1014 Year: 2009
Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors Source: Eur Respir J 2010; 35: 598-615 Year: 2010
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia Source: Eur Respir J 2009; 34: 1148-1158 Year: 2009
Risk factors for methicillin-resistant Staphylococcus aureus isolation from serially obtained sputum in patients hospitalized with pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020
Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review Source: Eur Respir J 2008; 31: 625-632 Year: 2008
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002
Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006
Vancomycin MICs for respiratory isolates of community-associated MRSA and hospital-associated MRSA Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007
Treatment challenges in methicillin resistant Staphylococcus aureus infections Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006
An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets Source: Eur Respir J 2010; 36: 901-906 Year: 2010
Significance of methicillin-resistant staphylococcus aureus in lower respiratory tract infections Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008
Aetiopathogenesis of VAP revisited Source: Eur Respir Mon 2011; 53: 1-10 Year: 2011
Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial Source: Eur Respir J 2004; 23: 921-926 Year: 2004
The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection Source: Eur Respir J 2002; 20: Suppl. 38, 357s Year: 2002